Home   Boston   Article

Subscribe Now

Professor Karen Dunderdale appointed new group chief executive of United Lincolnshire Hospitals NHS Trust and Lincolnshire Community Health Services NHS Trust

The appointment of a new health boss into one of Lincolnshire’s most important leadership roles has been hailed as a ‘significant milestone’.

Professor Karen Dunderdale has been announced as the new group chief executive of United Lincolnshire Hospitals NHS Trust and Lincolnshire Community Health Services NHS Trust.

The current deputy CEO will take over from Andrew Morgan from July 1, as he plans to retire after five years as United Lincolnshire Hospitals NHS Trust (ULHT) chief executive, and a year as the joint chief for Lincolnshire Community Health Services NHS Trust (LCHS).

Professor Karen Dunderdale
Professor Karen Dunderdale

Both ULHT and LCHS merged into a group model back in 2023, sharing capabilities and enhancing health services in Lincolnshire as a result, meaning one chief executive would reside over both trusts at the helm of busy hospitals in Boston and Lincoln.

Andrew Morgan has been chief executive of both trusts for the last 12 months, but Karen Dunderdale will be the group’s first official substantive CEO when she takes her post in July.

Get the news delivered straight to your inbox every morning - sign up to The Briefing here

Mr Morgan had been due to step down at the end of March 2024, but that was pushed back to allow for a full recruitment process to take place, and news of his replacement was announced at the NHS Lincolnshire Integrated Care Board meeting on Tuesday, March 26.

Andrew Morgan. Photo: Local Democracy Reporters
Andrew Morgan. Photo: Local Democracy Reporters

Professor Dunderdale has over three decades of experience in the medical sector, both as a cardiac nurse and also a director of nursing for a number of health trusts.

She was tasked with the director of nursing role at United Lincolnshire Hospitals NHS Trust in 2020, initially on an interim basis, but has been in that role ever since, navigating through the COVID-19 pandemic in the process.

The current deputy chief executive and executive chief nurse will take the big leap to lead two vital NHS trusts, which are collectively responsible for five major hospitals in Lincolnshire, as well as adult and children’s community health services.

It is a job packed with pressure but offers a financial incentive. According to ULHT’s annual report and accounts for 2022/23, the CEO position pays £232,500 a year; which is almost five times higher than the 25th percentile of workers at the trust (£47,486).

It marks an era of change at these two health trusts, with Elaine Baylis also preparing for her new role as Group Chair for both ULHT and LCHS from April 1.

Elaine Baylis
Elaine Baylis

Baylis brings over 45 years of public sector experience to the role, and was formerly the chair of LCHS until March 2023, so her experience will be crucial as Andrew Morgan and his four decades of healthcare work depart the sector later this year.

Group Chair-designate Elaine Baylis said: “We are delighted to announce that Professor Karen Dunderdale has been appointed as Group Chief Executive Officer (CEO) for LCHS and ULHT.

“This appointment has been made following an extensive national open recruitment process.

“Karen is currently our Group Deputy Chief Executive and Executive Chief Nurse, and will commence her new role on Monday 1 July 2024 following the departure of Andrew Morgan as Group CEO.

“This appointment is a significant milestone in the establishment of the group, and will enable us to further progress work on coming together as a group across the two organisations.”

Elsewhere in Lincolnshire’s health sector, Kevin Lockyer has been re-appointed as the chair of Lincolnshire Partnership NHS Foundation Trust for a further three years, keeping him in the role until at least April 30, 2027.

What do you think should be Prof Dunderdale’s priorities? Let us know your views in the comments below...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More